Atlas Trials

Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease

Clinical trial NCT01315795 · COMPLETED

Trial details

NCT number
NCT01315795
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Polycystic Liver Disease
Start date
2011-03-01
Primary completion
2014-07-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.